跳至主要内容
临床试验/DRKS00025802
DRKS00025802招募中未知

Gut Health Study - effectiveness of probiotics (OMNI-BiOTiC 10) combined with individual nutritional counselling with focus on prebiotic nutrition compared to solely individual nutritional counselling to improve gastrointestinal symptoms of bowel cancer survivors - a prospective double-blind randomized placebo-controlled trial - GutHealth

niversitäres Cancer Center Hamburg (UCCH) - Hubertus Wald Tumorzentrum0 个研究点目标入组 40 人开始时间: 2022年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • patients after bowel cancer disease with gastrointestinal symptoms
  • - 3 months to 5 years after cessation of cancer treatment
  • - expectancy > 6 months
  • - full-aged
  • - written informed consent

排除标准

  • - active infections > level 2 NCI-CTCAE V5.0
  • - severe systemic disease such as uncontrolled hypertension, heart failure or uncorntolled hyperglycaemia
  • - course of antibiotics in the past 8 weeks
  • - uncontrolled diabetes type 1 or 2
  • - immunosuppressive therapy, slow-healing wounds, ulcers, bone fractures
  • - pregnant women or those wishing to become pregnant as well as patients who do not apply contraceptive methods
  • - all conditions that could possibly compromise study outcome or patients safety
  • - all familial, psychologial or socialogical conditions that do not comply with the protocol
  • - participation in a study with an investigational product in the last 15 days before inclusion
  • - incarcerated patients
  • - enteral supplementation or parenteral nutrition or sip feeds (when covering over 50% of energy demand) after therapy of tumor cachexia
  • - presence of intestinal stenosis

研究者

发起方
niversitäres Cancer Center Hamburg (UCCH) - Hubertus Wald Tumorzentrum

相似试验